Plasma growth differentiation factor − 8 / Myostatin level as prognostic biomarker of patients with ischemic stroke and acute revascularization therapy. PARADISE study
This study aimed to assess the association between plasma Growth Differentiation Factor-8 (GDF-8)/Myostatin levels and outcome of IS patients.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Pauline Jakubina, Alexandre Meloux, Gauthier Duloquin, Serge Aho, Catherine Vergely, Yannick B éjot Source Type: research